Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 19.17B | 17.50B | 15.96B | 14.05B | 13.33B |
Gross Profit | 11.54B | 10.94B | 9.68B | 8.44B | 7.95B |
EBITDA | 2.86B | 2.59B | 2.31B | 1.73B | 2.10B |
Net Income | 854.56M | 739.69M | 846.76M | 483.62M | 1.17B |
Balance Sheet | |||||
Total Assets | 18.03B | 15.69B | 14.57B | 11.51B | 11.06B |
Cash, Cash Equivalents and Short-Term Investments | 8.46B | 6.66B | 6.68B | 4.59B | 4.67B |
Total Debt | 3.02B | 2.01B | 1.96B | 693.48M | 524.70M |
Total Liabilities | 8.54B | 7.03B | 6.62B | 4.36B | 3.77B |
Stockholders Equity | 9.46B | 8.64B | 7.93B | 7.13B | 7.00B |
Cash Flow | |||||
Free Cash Flow | 1.23B | 267.18M | 293.69M | 327.16M | 614.76M |
Operating Cash Flow | 2.81B | 2.20B | 1.68B | 1.56B | 1.90B |
Investing Cash Flow | -1.60B | -1.80B | -1.14B | -1.19B | -1.16B |
Financing Cash Flow | 280.79M | -645.92M | 763.68M | -822.04M | -64.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥23.90B | 23.92 | 0.59% | 20.51% | 94.75% | ||
74 Outperform | ¥25.78B | 13.20 | 4.30% | 13.54% | 15.43% | ||
67 Neutral | ¥25.56B | 33.53 | 1.61% | 5.38% | -8.86% | ||
66 Neutral | ¥23.35B | 22.49 | 1.52% | 1.80% | -10.15% | ||
61 Neutral | $36.30B | 7.26 | -7.27% | 1.97% | 7.74% | -7.92% | |
60 Neutral | ¥36.56B | 139.22 | ― | -17.30% | ― |
GMO GlobalSign Holdings K.K. announced a revision to its shareholder benefit program due to GMO Click Securities’ decision to eliminate stock trading commissions starting September 1, 2025. The revised program will now offer shareholders Bitcoin grants instead of transaction fee reimbursements, reflecting the company’s commitment to delivering value through innovative means while maintaining shareholder trust.
GMO GlobalSign Holdings K.K. reported its consolidated financial results for the first half of 2025, showing a slight increase in net sales by 4% compared to the previous year. However, the company experienced a decline in operating profit by 20.2% and ordinary profit by 28.7%, indicating challenges in maintaining profitability. Despite these setbacks, the company forecasts a positive outlook for the full fiscal year, with expected increases in net sales and profits, suggesting strategic adjustments to improve financial performance.